1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 75, 2024
  5. Article

Annual Review of Medicine

Volume 75, 2024

Spectrum of Diabetic Neuropathy: New Insights in Diagnosis and Treatment

Abstract

Diabetic neuropathy is a highly prevalent complication of diabetes. It consists of a broad range of neuropathic conditions, such as distal symmetric polyneuropathy and various forms of autonomic neuropathies involving the cardiovascular, gastrointestinal, and urogenital systems. Prevention or diagnosis in early stages of disease is crucial to prevent symptomatic onset and progression, particularly in the absence of current disease-modifying therapies. In this review, we describe the four main types of diabetic neuropathy. We review current understanding with respect to diagnosis and treatment while highlighting knowledge gaps and future directions.

Keyword(s): autonomic neuropathy, cardiovascular autonomic neuropathy, diabetic neuropathy, diabetic peripheral neuropathy, gastroparesis, urogenital neuropathy
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-043021-033114
2024-01-29
2024-05-06
Loading full text...

Full text loading...

/deliver/fulltext/med/75/1/annurev-med-043021-033114.html?itemId=/content/journals/10.1146/annurev-med-043021-033114&mimeType=html&fmt=ahah

Literature Cited

  1. 1.
    Pop-Busui R, Boulton AJM, Feldman EL et al. 2017. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40:136–54
     [Google Scholar]
  2. 2.
    Ang L, Mizokami-Stout K, Eid SA et al. 2022. The conundrum of diabetic neuropathies—past, present, and future. J. Diabetes Complications 36:108334
     [Google Scholar]
  3. 3.
    Sun H, Saeedi P, Karuranga S et al. 2022. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183:109119
     [Google Scholar]
  4. 4.
    Gordois A, Scuffham P, Shearer A et al. 2003. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 26:1790–95
     [Google Scholar]
  5. 5.
    Pop-Busui R, Ang L, Boulton AJM et al. 2022. Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy Arlington, VA: Am. Diabetes Assoc.
  6. 6.
    Braffett BH, Gubitosi-Klug RA, Albers JW et al. 2020. Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes 69:1000–10
     [Google Scholar]
  7. 7.
    Tesfaye S, Stevens LK, Stephenson JM et al. 1996. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39:1377–84
     [Google Scholar]
  8. 8.
    Mizokami-Stout KR, Li Z, Foster NC et al. 2020. The contemporary prevalence of diabetic neuropathy in type 1 diabetes: findings from the T1D Exchange. Diabetes Care 43:806–12
     [Google Scholar]
  9. 9.
    Ang L, Jaiswal M, Martin C, Pop-Busui R. 2014. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr. Diabetes Rep. 14:528
     [Google Scholar]
  10. 10.
    Andersen ST, Witte DR, Dalsgaard EM et al. 2018. Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care 41:1068–75
     [Google Scholar]
  11. 11.
    Mather KJ, Bebu I, Baker C et al. 2020. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes—A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res. Clin. Pract. 165:108235
     [Google Scholar]
  12. 12.
    Pop-Busui R, Lu J, Brooks MM et al. 2013. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) cohort. Diabetes Care 36:3208–15
     [Google Scholar]
  13. 13.
    Ang L, Dillon B, Mizokami-Stout K, Pop-Busui R. 2020. Cardiovascular autonomic neuropathy: a silent killer with long reach. Auton. Neurosci. 225:102646
     [Google Scholar]
  14. 14.
    Low PA, Benrud-Larson LM, Sletten DM et al. 2004. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 27:2942–47
     [Google Scholar]
  15. 15.
    Dabelea D, Stafford JM, Mayer-Davis EJ et al. 2017. Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 317:825–35
     [Google Scholar]
  16. 16.
    Jaiswal M, Divers J, Urbina EM et al. 2018. Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth cohort study. Pediatr. Diabetes 19:680–89
     [Google Scholar]
  17. 17.
    Ziegler D, Rathmann W, Dickhaus T et al. 2008. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464–69
     [Google Scholar]
  18. 18.
    Bongaerts BW, Rathmann W, Heier M et al. 2013. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study. Diabetes Care 36:1141–46
     [Google Scholar]
  19. 19.
    Stein P, Barzilay J, Domitrovich P et al. 2007. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study. Diabet. Med. 24:855–63
     [Google Scholar]
  20. 20.
    Callaghan BC, Xia R, Banerjee M et al. 2016. Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status. Diabetes Care 39:801–7
     [Google Scholar]
  21. 21.
    Christensen DH, Knudsen ST, Gylfadottir SS et al. 2020. Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: a nationwide study of 5,249 patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort. Diabetes Care 43:1266–75
     [Google Scholar]
  22. 22.
    Hicks CW, Wang D, Matsushita K et al. 2021. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study. Ann. Intern. Med. 174:167–74
     [Google Scholar]
  23. 23.
    Kahkoska AR, Pokaprakarn T, Alexander GR et al. 2022. The impact of racial and ethnic health disparities in diabetes management on clinical outcomes: a reinforcement learning analysis of health inequity among youth and young adults in the SEARCH for Diabetes in Youth study. Diabetes Care 45:108–18
     [Google Scholar]
  24. 24.
    Gagne A, Marcus H, Dawood T et al. 2022. Prevalence and patient recognition of distal symmetric neuropathy (DSP) in a predominantly low-income U.S. patient population. Diabetes 71:Suppl. 1461-P ( Abstr. )
     [Google Scholar]
  25. 25.
    Tan T-W, Shih C-D, Concha-Moore KC et al. 2019. Disparities in outcomes of patients admitted with diabetic foot infections. PLOS ONE 14:e0211481
     [Google Scholar]
  26. 26.
    Tan T-W, Calhoun EA, Knapp SM et al. 2022. Rates of diabetes-related major amputations among racial and ethnic minority adults following Medicaid expansion under the Patient Protection and Affordable Care Act. JAMA Netw. Open 5:e223991
     [Google Scholar]
  27. 27.
    Hill-Briggs F, Adler NE, Berkowitz SA et al. 2020. Social determinants of health and diabetes: a scientific review. Diabetes Care 44:258–79
     [Google Scholar]
  28. 28.
    Jeyam A, McGurnaghan SJ, Blackbourn LAK et al. 2020. Diabetic neuropathy is a substantial burden in people with type 1 diabetes and is strongly associated with socioeconomic disadvantage: a population-representative study from Scotland. Diabetes Care 43:734–42
     [Google Scholar]
  29. 29.
    Blair Y, Wessells H, Pop-Busui R et al. 2022. Urologic complications in diabetes. J. Diabetes Complicat. 36:108288
     [Google Scholar]
  30. 30.
    Sarma AV, Kanaya A, Nyberg LM et al. 2009. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the Epidemiology of Diabetes Interventions and Complications study. Urology 73:1203–9
     [Google Scholar]
  31. 31.
    Enzlin P, Rosen R, Wiegel M et al. 2009. Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort. Diabetes Care 32:780–85
     [Google Scholar]
  32. 32.
    Brown JS, Vittinghoff E, Lin F et al. 2006. Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose. Diabetes Care 29:1307–12
     [Google Scholar]
  33. 33.
    Van Den Eeden SK, Sarma AV, Rutledge BN et al. 2009. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care 32:664–70
     [Google Scholar]
  34. 34.
    Wessells H, Penson DF, Cleary P et al. 2011. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J. Urol. 185:1828–34
     [Google Scholar]
  35. 35.
    Ang L, Cowdin N, Mizokami-Stout K, Pop-Busui R. 2018. Update on the management of diabetic neuropathy. Diabetes Spectr. 31:224–33
     [Google Scholar]
  36. 36.
    Feldman EL, Callaghan BC, Pop-Busui R et al. 2019. Diabetic neuropathy. Nat. Rev. Dis. Primers 5:41
     [Google Scholar]
  37. 37.
    Pop-Busui R, Backlund JYC, Bebu I et al. 2022. Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type1 diabetes patients. J. Diabetes Investig. 13:125–33
     [Google Scholar]
  38. 38.
    Rosen R, Brown C, Heiman J et al. 2000. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J. Sex Marital Ther. 26:191–208
     [Google Scholar]
  39. 39.
    Rosen RC, Riley A, Wagner G et al. 1997. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–30
     [Google Scholar]
  40. 40.
    Pop-Busui R, Ang L, Holmes C et al. 2016. Inflammation as a therapeutic target for diabetic neuropathies. Curr. Diabetes Rep. 16:29
     [Google Scholar]
  41. 41.
    Nathan DM, Genuth S, Lachin J et al. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977–86
     [Google Scholar]
  42. 42.
    Albers JW, Kenny DJ, Brown M et al. 1995. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann. Neurol. 38:869–80
     [Google Scholar]
  43. 43.
    Ismail-Beigi F, Craven T, Banerji MA et al. 2010. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376:419–30
     [Google Scholar]
  44. 44.
    Lewis EJH, Lovblom LE, Lanctot S et al. 2022. The association between physical activity time and neuropathy in longstanding type 1 diabetes: a cross-sectional analysis of the Canadian study of longevity in type 1 diabetes. J. Diabetes Complicat. 36:108134
     [Google Scholar]
  45. 45.
    Horton ES, Chen H, Nathan DM et al. 2017. Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study. Diabetologia 60:980–88
     [Google Scholar]
  46. 46.
    Singleton JR, Marcus RL, Jackson JE et al. 2014. Exercise increases cutaneous nerve density in diabetic patients without neuropathy. Ann. Clin. Transl. Neurol. 1:844–49
     [Google Scholar]
  47. 47.
    Gaede P, Vedel P, Larsen N et al. 2003. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348:383–93
     [Google Scholar]
  48. 48.
    Singleton JR, Marcus RL, Lessard MK et al. 2015. Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients. Ann. Neurol. 77:146–53
     [Google Scholar]
  49. 49.
    Morrison S, Colberg SR, Parson HK, Vinik AI. 2014. Exercise improves gait, reaction time and postural stability in older adults with type 2 diabetes and neuropathy. J. Diabetes Complicat. 28:715–22
     [Google Scholar]
  50. 50.
    Finnerup NB, Kuner R, Jensen TS. 2021. Neuropathic pain: from mechanisms to treatment. Physiol. Rev. 101:259–301
     [Google Scholar]
  51. 51.
    Tesfaye S, Sloan G, Petrie J et al. 2022. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 400:680–90
     [Google Scholar]
  52. 52.
    Jensen TS, Karlsson P, Gylfadottir SS et al. 2021. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain 144:1632–45
     [Google Scholar]
  53. 53.
    Blonde L, Umpierrez GE, Reddy SS et al. 2022. American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update. Endocr. Pract. 28:923–1049
     [Google Scholar]
  54. 54.
    Petersen EA, Stauss TG, Scowcroft JA et al. 2021. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy. JAMA Neurol. 78:687
     [Google Scholar]
  55. 55.
    Van Laake-Geelen CCM, Smeets RJEM, Quadflieg SPAB et al. 2019. The effect of exercise therapy combined with psychological therapy on physical activity and quality of life in patients with painful diabetic neuropathy: a systematic review. Scand. J. Pain 19:433–39
     [Google Scholar]
  56. 56.
    Martin CL, Albers JW, Pop-Busui R. 2014. Neuropathy and related findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care 37:31–38
     [Google Scholar]
  57. 57.
    Pop-Busui R, Low PA, Waberski BH et al. 2009. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 119:2886–93
     [Google Scholar]
  58. 58.
    Bönhof GJ, Strom A, Apostolopoulou M et al. 2022. High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes. Diabetologia 65:1048–57
     [Google Scholar]
  59. 59.
    Wegeberg A-ML, Okdahl T, Fløyel T et al. 2020. Circulating inflammatory markers are inversely associated with heart rate variability measures in type 1 diabetes. Mediators Inflamm. 2020:3590389
     [Google Scholar]
  60. 60.
    Ang L, Gunaratnam SVG, Huang Y et al. 2022. Inflammatory markers and cardiovascular autonomic neuropathy in type 1 diabetes. Diabetes 71:Suppl. 1458-P ( Abstr. )
     [Google Scholar]
  61. 61.
    Lenherr SM, Clemens JQ, Braffett BH et al. 2016. Glycaemic control and risk of incident urinary incontinence in women with type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabet. Med. 33:1528–35
     [Google Scholar]
  62. 62.
    Phelan S, Kanaya AM, Subak LL et al. 2012. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J. Urol. 187:939–44
     [Google Scholar]
  63. 63.
    Phelan S, Kanaya AM, Ma Y et al. 2015. Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study. Int. J. Urol. 22:206–12
     [Google Scholar]
  64. 64.
    Muniyappa R, Norton M, Dunn ME, Banerji MA. 2005. Diabetes and female sexual dysfunction: moving beyond “benign neglect. .” Curr. Diabetes Rep. 5:230–36
     [Google Scholar]
  65. 65.
    Wing RR, Rosen RC, Fava JL et al. 2010. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J. Sex. Med. 7:156–65
     [Google Scholar]
  66. 66.
    Agochukwu-Mmonu N, Pop-Busui R, Wessells H, Sarma AV. 2020. Autonomic neuropathy and urologic complications in diabetes. Auton. Neurosci. 229:102736
     [Google Scholar]
/content/journals/10.1146/annurev-med-043021-033114
Loading
Spectrum of Diabetic Neuropathy: New Insights in Diagnosis and Treatment
Annual Review of Medicine 75, 293 (2024); https://doi.org/10.1146/annurev-med-043021-033114
/content/journals/10.1146/annurev-med-043021-033114
/content/journals/10.1146/annurev-med-043021-033114
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error